ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Program Project Guidelines Available

October 27, 1995

President Accepts Rauscher Resignation

October 1, 1976

DOD Names Innovator Award Recipients.

April 26, 2002

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000